Cargando…
Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources Database
INTRODUCTION: As patient registries are not subject to regulatory requirements on the collection of adverse events (AEs) related to medicinal products, they may not have foreseen the collection of such information on a routine basis or as part of specific data collection schemes. OBJECTIVE: The Euro...
Autores principales: | Plueschke, Kelly, Jonker, Carla, Strassmann, Valerie, Kurz, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296377/ https://www.ncbi.nlm.nih.gov/pubmed/35729468 http://dx.doi.org/10.1007/s40264-022-01188-x |
Ejemplares similares
-
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies
por: Gini, Rosa, et al.
Publicado: (2019) -
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
por: Kurz, Xavier, et al.
Publicado: (2018) -
An analysis of characteristics of post-authorisation studies registered on the ENCePP EU PAS Register
por: Carroll, Robert, et al.
Publicado: (2017) -
Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
por: Jonker, Carla J., et al.
Publicado: (2022) -
Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments
por: McGettigan, Patricia, et al.
Publicado: (2019)